Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$51.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Jun 5 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 960,983 | $52.03 | $50M | +124.9% | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 22,319 | $52.03 | $1.2M | +10.3% | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 6,510 | $52.03 | $338.7K | +10.3% | Open the original filing on SEC.gov |
| Jun 10, 2025 | DSGN | Design Therapeutics, Inc. | AGRANT◆ | 19,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | NKTX | Nkarta, Inc. | AGRANT◆ | 46,000 | — | — | — | Open the original filing on SEC.gov |